Bausch Health Companies Inc.·4

May 26, 7:05 PM ET

WECHSLER AMY B 4

4 · Bausch Health Companies Inc. · Filed May 26, 2026

Research Summary

AI-generated summary of this filing

Updated

Bausch Health (BHC) Director Amy Wechsler Receives RSU Award

What Happened
Amy B. Wechsler, a non‑employee director of Bausch Health Companies Inc. (BHC), was granted 45,871 restricted share units (RSUs) on 2026-05-22. The Form 4 reports the acquisition as an award (code A) at $0.00 per share (no cash paid). Per the filing footnote, the RSUs have a grant‑date value of $250,000, will vest on the date immediately preceding the issuer’s next Annual Meeting of Shareholders, and will be settled in common shares.

Key Details

  • Transaction date: 2026-05-22; reported on Form 4 filed 2026-05-26.
  • Transaction type/code: Award of RSUs (A); reported acquisition of 45,871 shares at $0.00 (total cash value shown as $0).
  • Grant value: Footnote states grant‑date value of $250,000 for the director award (settled in shares when vested).
  • Vesting/settlement: RSUs vest immediately before the next annual meeting and are settled in common shares.
  • Shares owned after transaction: Not specified in the filing.
  • Timeliness: Filing date is 2026-05-26; the filing does not indicate a late report.

Context
This was an equity award to a non‑employee director, a routine form of compensation rather than an open‑market purchase or sale. Awards like RSUs are not direct buys/sells and do not necessarily signal immediate trading intent; they convert to shares upon vesting and settlement.

Insider Transaction Report

Form 4
Period: 2026-05-22
Transactions
  • Award

    Common Shares, No Par Value

    [F1]
    2026-05-22+45,871313,585 total
Footnotes (1)
  • [F1]Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.
Signature
/s/ Brianna M. Dorsi, attorney-in-fact|2026-05-26

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT